 |
|
Pembrolizumab-Induced Nasal Polyposis: The First Reported Case
Justin M. Hintze, Holly Jones, Peter Lacy
J Rhinol. 2023;30(2):125-128. Published online 2023 Jul 28 DOI: https://doi.org/10.18787/jr.2023.00022
|
|
Citations to this article as recorded by
 Association of Sinonasal Symptoms and Disease With Immune Checkpoint Inhibitor Therapy
Jaynelle Gao, Ryan S. Chung, Jason Chwa, Kevin Hur
Laryngoscope Investigative Otolaryngology.2025;[Epub] CrossRef Immune Checkpoint Inhibitor (ICI) Induced Sinonasal Disease: Review of Literature and FDA Database
Kaitlynne Y. Pak, Wasiq Nadeem, Victor Lee, Dennis M. Tang, Arthur W. Wu
Annals of Otology, Rhinology & Laryngology.2024; 133(10): 893. CrossRef Symptomatic aseptic sinusitis induced by immune checkpoint inhibitors for metastatic melanoma treatment
Sofia Tzoumpa, Béatrice Villette, Florence Granel-Brocard, Caroline Dutriaux, Alexandre Memmi, Geraldine Jeudy, Victor Tafani, Melanie Saint-Jean, Charlee Nardin, Elisa Funck-Brentano, Yannick Le Corre, Gaëlle Quereux, Eve Maubec
Immunotherapy.2024; 16(16-17): 1029. CrossRef Ears, Nose, and Throat in Leukemias and Lymphomas
Pinelopi Samara, Michail Athanasopoulos, Ioannis Athanasopoulos
Encyclopedia.2024; 4(4): 1891. CrossRef
|